Clinical Trial Update: Prophylactic Probiotics in Premature Infants [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating prophylactic probiotics in premature infants was terminated, with the study aiming to reduce death and hospital-acquired infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• Probiotic (probiotic)

Snippet

Sponsor: Colombian Neonatal Research Network | Conditions: Death, Nosocomial Infection | Phase 3 | Status: TERMINATED